Article Contents ::
- 1 The Brand Name POPUP Has Generic Salt :: TADALAFIL
- 2 POPUP Is From Company NPIL Priced :: Rs. 90
- 3 POPUP have TADALAFIL is comes under Sub class Drugs for Erectile Dysfunction,Libido,Infertility of Main Class Reproductive System
- 4 Main Medicine Class:: Reproductive System Sub Medicine Class :: Drugs for Erectile Dysfunction,Libido,Infertility
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name POPUP Has Generic Salt :: TADALAFIL
POPUP Is From Company NPIL Priced :: Rs. 90
POPUP have TADALAFIL is comes under Sub class Drugs for Erectile Dysfunction,Libido,Infertility of Main Class Reproductive System
Main Medicine Class:: Reproductive System Sub Medicine Class :: Drugs for Erectile Dysfunction,Libido,Infertility
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
Indications for Drugs ::
Erectile dysfunction, signs and symptoms of benign prostatic hyperplasia (BPH)
Drug Dose ::
Oral Erectile dysfunction Adult: Initially, 10 mg at least 30 min before sexual activity once daily, up to 20 mg as single dose. Max: Not more than once daily. If used with potent inhibitors of CYP3A4, e.g. azole antifungals or protease inhibitors: max 10 mg once every 72 hr. Benign Prostatic Hyperplasia The recommended dose is 5 mg, taken at approximately the same time every day. Renal impairment: CrCl (ml/min) 31-50 Initial dose at 5 mg/day. Max: 10 mg/48hr <30 Max: 5 mg/24hr. Hepatic impairment: Mild-moderate hepatic impairment (Child-Pugh category A or B): Max dose 10 mg. Severe hepatic impairment (Child-Pugh category C): Not recommended. Contraindication ::
Concurrent use of organic nitrates, nitrates and nitric oxide donors. Men with cardiac disease for whom sexual activity is inadvisable. Recent MI (within 90 days) or stroke (within last 6 mth), hypotension (<90/50 mm Hg), unstable angina, heart failure, uncontrolled arrhythmias or hypertension. Drug Precautions ::
Hepatic or renal impairment; CV diseases; anatomical penile deformation; predisposition to priapism; child <18 yr. Discontinue and seek medical advice if there is sudden vision loss or decreased vision in one or both eyes or tinnitus, dizziness or sudden loss or decrease in hearing, while taking Tadalafil. Seek immediate medical advice if erection last > 4 hr.
Drug Side Effects ::
Headache, dyspepsia, dizziness, flushing, swelling of eyelids, eye pain, conjunctival hyperemia, back pain, myalgia, visual disturbances, nasal congestion, sudden decrease or loss of hearing, tinnitus. Potentially Fatal: Stevens-Johnson syndrome, exfoliative dermatitis, severe cardiovascular events e.g. MI, stroke, sudden cardiac death;
Pregnancy category ::
Drug Mode of Action ::
Tadalafil is a phosphodiesterase type-5 inhibitor.
Drug Interactions ::
Concurrent use increased risk of hypotension with beta-blockers; increased risk of priapism with other drugs for erectile dysfunction, e.g. alprostadil; increased heart rate with theophylline; decreased tadalafil serum concentration with CYP 3A4 inducers e.g. rifampicin, efavirenz, carbamazepine, nevirapine, barbiturates, phenobarbital, phenytoin, ribabutin; increased tadalafil serum concentration with CYP3A4 inhibitors e.g. azole antifungals, protease inhibitors, cimetidine, macrolides. Potentially Fatal: Enhanced hypotensive effect with nitrates and nicorandil.